INIS
ablation
7%
assessments
11%
biological markers
6%
birth
22%
blood
6%
cancer
49%
carcinomas
8%
carriers
5%
chemotherapy
6%
children
8%
comparative evaluations
32%
control
13%
cost
11%
data
18%
delivery
14%
design
9%
detection
5%
diseases
17%
evaluation
6%
females
6%
fertility
5%
fertilization
5%
fetuses
5%
genetics
5%
growth
9%
guidelines
8%
gynecology
5%
hospitals
14%
humans
8%
hypertension
5%
in vitro
6%
induction
5%
interventions
12%
labor
13%
length
5%
levels
12%
losses
7%
management
11%
membranes
5%
mortality
6%
netherlands
22%
obstetrics
9%
ovaries
38%
pain
7%
patients
62%
performance
5%
placenta
5%
plasma
5%
populations
9%
prediction
12%
pregnancy
52%
quality of life
8%
range
5%
reviews
32%
risks
44%
ruptures
5%
screening
5%
surgery
30%
surveys
5%
symptoms
7%
testing
6%
therapy
6%
tumors
13%
validation
5%
values
11%
volume
7%
weight
6%
women
100%
Medicine and Dentistry
Biological Marker
5%
Bleeding
6%
Cesarean Section
7%
Childbirth
7%
Cohort Analysis
9%
Cost-Effectiveness Analysis
7%
Cytoreductive Surgery
7%
Disease
11%
Endometrial Ablation
6%
Endometrial Cancer
11%
Endometriosis
6%
First Trimester Pregnancy
6%
Gestational Age
6%
Gynecology
6%
Health Care Cost
8%
Hysterectomy
7%
Krukenberg Tumor
8%
Menorrhagia
6%
Meta-Analysis
17%
Neoplasm
8%
Obstetrics
7%
Odds Ratio
6%
Ovarian Cancer
20%
Overall Survival
5%
Pre-Eclampsia
20%
Pregnancy
8%
Premature Labor
12%
Prospective Cohort Study
6%
Quality of Life
7%
Randomized Controlled Trial
28%
Recurrent Disease
5%
Retrospective Cohort Study
5%
Surgery
5%
Symptom
5%
Systematic Review
21%
Keyphrases
Abnormal Uterine Bleeding
7%
Advanced Ovarian Cancer
6%
Confidence Interval
12%
Cost-effectiveness
5%
During Pregnancy
5%
Dutch
11%
Endometrial Ablation
6%
Endometrial Cancer
10%
Endometriosis
6%
Epithelial Ovarian Cancer
5%
Fetus
5%
Gestational Age
5%
Meta-analysis
16%
Netherlands
23%
Ovarian Cancer
10%
Overall Survival
5%
Pre-eclamptic Women
6%
Prediction Model
5%
Preeclampsia
21%
Preterm Birth
5%
Prospective Cohort Study
6%
Randomized Controlled Trial
23%
Retrospective Cohort Study
5%
Systematic Meta-analysis
14%
Week of Gestation
5%